Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000084.xml
Synthesis 2006(11): 1791-1802
DOI: 10.1055/s-2006-926466
DOI: 10.1055/s-2006-926466
PAPER
© Georg Thieme Verlag Stuttgart · New York
Synthesis of Novel Conformationally Constrained Pyrazolo[4,3-c]quinoline Derivatives as Potential Ligands for the Estrogen Receptor
Further Information
Received
10 August 2005
Publication Date:
27 April 2006 (online)
Publication History
Publication Date:
27 April 2006 (online)
Abstract
The preparation of three novel classes of pyrazolo[4,3-c]quinoline derivatives is reported. The easily accessible 2,3-dihydro-1H-quinolin-4-ones were used as the starting materials and were functionalized with three different acylating agents affording their respective constrained core substrates. The latter by condensation with phenyl(or 4-methoxyphenyl)hydrazines and subsequent debenzylation or demethylation provided the desired pyrazole derivatives. Some interesting features emerged with respect to the regioselectivity and mechanism of these reactions.
Key words
quinolines - fused ring-systems - acylations - pyrazole - estrogens
- 1
Gao H.Katzenellenbogen JA.Garg R.Hansch C. Chem. Rev. 1999, 99: 723 - 2
Magarian RA.Overaacre LB.Singh S. Curr. Med. Chem. 1994, 1: 61 - 3
Grundy J. Chem. Rev. 1957, 57: 281 - 4
Compton DR.Carlson KE.Katzenellenbogen JA. Bioorg. Med. Chem. Lett. 2004, 14: 5681 - 5
Jordan VC. Trends Endocrinol. Metab. 1999, 10: 312 - 6
Meegan MJ.Hughes RB.Lloyd DG.Williams DC.Zisterer DM. J. Med. Chem. 2001, 44: 1072 - 7
Arnal JF.Gourdy P.Bayard LF.Filippe C. Drug Discov. Today: Dis. Model. 2004, 23: 213 - 8
Delmas PD.Bjarnason NH.Mitlak BH.Ravoux AC.Shah AS.Huster WJ.Draper M.Christianson C. N. Engl. J. Med. 1997, 337: 1641 - 9
Grese TA.Dogde JA. Curr. Pharm. Des. 1998, 4: 71 - 10
Kuiper GG.Enmark E.Pelto-Huikko M.Nilsson S.Gustafsson J.-A. Proc. Natl. Acad. Sci. U.S.A. 1996, 93: 5925 - 11
Pettersson K.Gustafsson JA. Ann. Rev. Physiol. 2001, 63: 165 - 12
Nilsson S.Kuiper G.Gustafsson JA. Trends Endocrinol. Metab. 1998, 9: 387 - 13
Stauffer SR.Coletta CJ.Tedesco R.Nishigushi G.Carlson K.Sun J.Katzenellenbogen BS.Katzenellenbogen JA. J. Med. Chem. 2000, 44: 4934 - 14
Fink BE.Mortensen DS.Stauffer SR.Aron ZD.Katzenellenbogen JA. Chem. Biol. 1999, 6: 205 - 15
Stauffer SR.Huang YR.Aron ZD.Coletta CJ.Sun J.Katzenellenbogen BS.Katzenellenbogen JA. Bioorg. Med. Chem. 2001, 9: 151 - 16
Lin X.Huebner V. Curr. Opin. Drug Discov. Dev. 2000, 3: 383 - 17
Baraldi PG.Borea PA. Trends Pharmacol. Sci. 2000, 21: 456 - 18
Colleta V.Catarzi D.Varano F.Cecchi L.Filacchiono G.Martini C.Lucacchini A. J. Med. Chem. 2000, 43: 3118 - 19
Eskildsen J.Østergaard N.Vedsø P.Begtrup M. Tetrahedron 2002, 58: 7635 - 20
Kuo S.-C.Lee H.-Z.Juang J.-P.Lin Y.-T.Wu T.-S.Chang J.-J.Lednicer D.Paull KD.Lin C.-M.Hamel E.Lee K.-H. J. Med. Chem. 1993, 36: 1146 - 21
Edwards JP.Higuchi RI.Winn DT.Pooley CLF.Caferro TR. Bioorg. Med. Chem. Lett. 1999, 7: 1003 - 22
Booker-Milburn KI.Dunkin IR.Kelly FC.Khalaf AI.David A. J. Chem. Soc., Perkin Trans. 1 1997, 3261 - 23
Wiles C.Watts P.Haswell SJ.Pombo-Villar E. Tetrahedron Lett. 2002, 43: 2945